Inflammation Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.2 | Q1 | 80.9% | 1.552 | Q1 | 92.5% |
| 2024 | 5.4 | Q1 | 81.0% | 1.388 | Q1 | 91.1% |
| 2023 | 4.8 | Q2 | 70.4% | 1.309 | Q1 | 90.8% |
| 2022 | 6.7 | Q2 | 75.0% | 1.339 | Q1 | 91.5% |
| 2021 | 7.0 | Q2 | 72.9% | 1.332 | Q1 | 91.5% |
| 2020 | — | — | 1.121 | Q1 | 87.6% | |
| 2019 | — | — | 0.980 | Q1 | 85.2% | |
| 2018 | — | — | 0.970 | Q2 | 83.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1023-3830
ISSN
1420-908X
region
Western Europe
coverage
1995-2026